A comparison of warfarin utilisation in North America and Ireland H Haji, K Wilby, M Mamdani Journal of Health Specialties 2 (3), 105-105, 2014 | | 2014 |
A course-based cross-cultural interaction among pharmacy students in Qatar and Canada KJ Wilby, J Taylor, SI Khalifa, D Jorgenson American journal of pharmaceutical education 79 (2), 26, 2015 | 18 | 2015 |
A critical evidence-based summary of the use of beta-blockers in stable coronary artery disease AL Cartwright, KJ Wilby Avicenna 2014 (1), 4, 2015 | | 2015 |
A critical review of the current evidence for measuring drug concentrations of first-line agents used to treat tuberculosis in children KJ Wilby, S Shabana, MHH Ensom, F Marra Clinical pharmacokinetics 55, 17-31, 2016 | 2 | 2016 |
A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline TKL Kiang, KJ Wilby, MHH Ensom Clinical pharmacokinetics 54, 915-931, 2015 | 36 | 2015 |
A Middle Eastern journey of integrating Interprofessional Education into the healthcare curriculum: a SWOC analysis A El-Awaisi, KJ Wilby, K Wilbur, MS El Hajj, A Awaisu, B Paravattil BMC medical education 17, 1-10, 2017 | 59 | 2017 |
A narrative review of continuing professional development needs for pharmacists with respect to pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) KJ Wilby, AJ Smith Pharmacy 8 (2), 84, 2020 | 16 | 2020 |
A psychometric analysis of a newly developed summative, multiple choice question assessment adapted from Canada to a Middle Eastern context SA Pawluk, K Shah, R Minhas, D Rainkie, KJ Wilby Currents in Pharmacy Teaching and Learning 10 (8), 1026-1032, 2018 | 9 | 2018 |
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies KJ Wilby, ZG Nasr, S Elazzazy, TTY Lau, A Hamad Drugs in R&D 17, 73-78, 2017 | 3 | 2017 |
A review of clinical pharmacokinetic and pharmacodynamic relationships and clinical implications for drugs used to treat multi-drug resistant tuberculosis KJ Wilby, FN Hussain European Journal of Drug Metabolism and Pharmacokinetics 45 (3), 305-313, 2020 | 6 | 2020 |
A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients KJ Wilby, ED Greanya, JAE Ford, EM Yoshida, N Partovi Annals of hepatology 11 (2), 179-185, 2012 | 93 | 2012 |
A review of pharmacogenetics of antimalarials and associated clinical implications H Elewa, KJ Wilby European journal of drug metabolism and pharmacokinetics 42, 745-756, 2017 | 39 | 2017 |
A review of pharmacokinetic drug–drug interactions with the anthelmintic medications albendazole and mebendazole SA Pawluk, CA Roels, KJ Wilby, MHH Ensom Clinical pharmacokinetics 54, 371-383, 2015 | 60 | 2015 |
A review of pharmacy‐led interventions: identification of facilitators and barriers for the design of a new model of care for asthma N Rajballi‐Naidoo, KJ Wilby, A Young, A Smith Journal of Pharmacy Practice and Research 53 (5), 227-240, 2023 | | 2023 |
A review of the clinical pharmacokinetics and pharmacodynamics of isavuconazole KJ Wilby European Journal of Drug Metabolism and Pharmacokinetics 43, 281-290, 2018 | 14 | 2018 |
A review of the effect of immunization programs on antimicrobial utilization KJ Wilby, D Werry Vaccine 30 (46), 6509-6514, 2012 | 45 | 2012 |
A review of the pharmacokinetic implications of schistosomiasis KJ Wilby, SE Gilchrist, MHH Ensom Clinical pharmacokinetics 52, 647-656, 2013 | 16 | 2013 |
A scoping review of antimicrobial stewardship teaching in pharmacy education curricula ZG Nasr, DM Abbara, KJ Wilby American Journal of Pharmaceutical Education 85 (6), 8415, 2021 | 9 | 2021 |
A scoping review of interprofessional education training aimed to improve 2SLGBTQ+ Health M McLean, D Bogle, C Diggins, M MacInnis, A MacDonald, KJ Wilby American Journal of Pharmaceutical Education, 100683, 2024 | 1 | 2024 |
A scoping review of the clinical pharmacokinetics of bedaquiline KJ Wilby Clinical Pharmacokinetics 61 (4), 481-488, 2022 | 5 | 2022 |